Navigation Links
Third Wave boosts numbers in latest report

Madison, Wis. Third Wave Technologies this week reported the best annual financial results in the company's short history, wrapping up a year in which it met or exceeded all of its stated fiscal expectations.

Third Wave reported total revenues of $46.5 million and a net loss of $1.9 million for the year ended December 31, compared to total revenues......

Full article >>> commitment to building strong relationships and releasing superior solutions was a powerful one during 2004."

Transition time


Third Wave VP of Finance Jim Herrmann noted that the company "will maintain a conservative position and guide to a lower amount in 2005." Company execs said Wednesday that Third Wave is in the middle of a transition, and that 2005 will bring more of the sa......

Full article >>> they're faced with a falloff in their genomics and research sales. The company has historically played in that area, and that business for them has been very successful; unfortunately, that business is winding down. It's an area the company is no longer aggressively going after, and 2005 for them is going to see a precipitous fall in revenues. I think the issue for company and the stock over the n......

Full article >>> reached at lincoln@wistechnology.com.
......

Full article >>>
'"/>

Source:wistechnology.com By Lincoln Brunner 02/23/05


Related biology technology :

1. Third Wave files countersuit vs. Digene in patent case
2. Third Wave reports net loss of $18.9M for 2006
3. Stratagene to pay Third Wave $10.75M in patent case
4. Third Wave responds to Digene patent lawsuit
5. Third Wave seeks approval of Cystic Fibrosis test
6. Third Wave Technologies to raise $14.9M through private debt
7. Third Wave reports $5.2M third quarter loss
8. Third Wave reports another loss, stronger sales
9. Napier joins board of Third Wave Technologies
10. Third Waves revenues rebound
11. Third Wave reports clinical growth, continued loss
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... San Francisco, CA (PRWEB) , ... June 23, ... ... capture (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase ... DIA Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting ...
(Date:6/23/2016)... Windsor, Connecticut (PRWEB) , ... June 23, 2016 ... ... will introduce a new line of intelligent tools designed, tuned and optimized exclusively ... place September 12–17 in Chicago. The result of a collaboration among several companies ...
Breaking Biology Technology:
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
Breaking Biology News(10 mins):